🇺🇸 FDA
Patent

US 11224659

Solid solution compositions and use in severe pain

granted A61KA61K31/121A61K31/137

Quick answer

US patent 11224659 (Solid solution compositions and use in severe pain) held by Infirst Healthcare Limited expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/121, A61K31/137, A61K31/167, A61K31/192